EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions

Laís Amorim Sacramento, Camila Farias Amorim, Claudia G Lombana, Daniel Beiting, Fernanda Novais, Lucas P Carvalho, Edgar M Carvalho, Phillip Scott iD

PLOS Pathogens · 2024

DOI: 10.1371/journal.ppat.1012211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Laís Amorim Sacramento und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America. Hauptthemen laut MEDLINE: Receptors, CCR5, CD8-Positive T-Lymphocytes, Cell Movement, Leishmaniasis, Cutaneous. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytolytic CD8 + T cells mediate immunopathology in cutaneous leishmaniasis without controlling parasites. Here, we identify factors involved in CD8 + T cell migration to the lesion that could be targeted to ameliorate disease severity. CCR5 was the most highly expressed chemokine receptor in patient lesions, and the high expression of CCL3 and CCL4, CCR5 ligands, was associated with delayed healing of lesions. To test the requirement for CCR5, Leishmania- infected Rag1 -/- mice were reconstituted with CCR5 -/- CD8 + T cells. We found that these mice developed smaller lesions accompanied by a reduction in CD8 + T cell numbers compared to controls. We confirmed these findings by showing that the inhibition of CCR5 with maraviroc, a selective inhibitor of CCR5, reduced lesion development without affecting the parasite burden. Together, these results reveal that CD8 + T cells migrate to leishmanial lesions in a CCR5-dependent manner and that blocking CCR5 prevents CD8 + T cell-mediated pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CCR5CD8-Positive T-LymphocytesCell MovementLeishmaniasis, CutaneousAnimalsMiceHumansMice, KnockoutMice, Inbred C57BLCCR5 Receptor AntagonistsMaravirocFemale

Substanzen

Receptors, CCR5CCR5 Receptor AntagonistsMaravirocCCR5 protein, mouseCCR5 protein, human

Autor:innen und Institutionen

  • Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
  • Laboratório de Pesquisas Clínicas do Instituto de Pesquisas Gonçalo Muniz-Fiocruz, Salvador, Bahia, Brazil.
  • Immunology Service, Professor Edgard Santos University Hospital Complex, Federal University of Bahia, Salvador, Bahia, Brazil.

ORCID-Profile: Phillip Scott

Förderung

  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Amorim Sacramento, L., Farias Amorim, C., G Lombana, C., Beiting, D., Novais, F., P Carvalho, L., M Carvalho, E., & Scott, P. (2024). CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012211

Vancouver

Amorim Sacramento L, Farias Amorim C, G Lombana C, Beiting D, Novais F, P Carvalho L, et al. CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012211

BibTeX
@article{AmorimSacramento2024,
  author = {Amorim Sacramento, Laís and Farias Amorim, Camila and G Lombana, Claudia and Beiting, Daniel and Novais, Fernanda and P Carvalho, Lucas and M Carvalho, Edgar and Scott, Phillip},
  title = {CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions},
  journal = {PLOS Pathogens},
  year = {2024},
  doi = {10.1371/journal.ppat.1012211}
}
Kostenlos starten →